Synthetic microbiome therapy suppresses bacterial infection without antibiotics

A synthetic microbiome therapy, tested in mice, holds promise as a new treatment for C. difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers at Penn State. The targeted treatment was as effective as human fecal transplants in mice against C. difficile infection with fewer safety concerns, protecting against severe symptoms and decreasing recurrent infections.